Clinical Trial Update: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986104 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 randomized, placebo-controlled, double-blind, single ascending-dose study of BMS-986104 in healthy male subjects. The trial assessed safety, tolerabilit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BMS-986104

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED